Professional Documents
Culture Documents
Radiology L2. Tuganbayeva Yenglik
Radiology L2. Tuganbayeva Yenglik
CT and MRI:
- indicated in retrosternal localization of the thyroid gland, as well as in case of
insufficient information content of ultrasound results
Radioisotope research:
- method of functional visualization of the thyroid gland.
- Of the radioisotopes of iodine
123I is less radiotoxic due to its short half-life (13 hours) and optimal energy
spectrum (photon energy – 159 keV).
131I (half-life – 8 days, photon energy 18 – 364 keV) is more often used
before radioiodine therapy for diffuse toxic goiter to determine the ability of the
thyroid gland to accumulate iodine.
The 99mTc-MIBI (half-life 6 hours, photon energy 140 keV) is designed for
myocardial scintigraphy. In thyroidology, it is used as a marker of malignant
neoplasms of the thyroid gland, due to its ability to actively accumulate in
mitochondria-rich tissues.
X-ray:
- is performed with barium contrast to the esophagus, which makes it possible
to assess the condition of the trachea and esophagus if their narrowing or
displacement is suspected
Classification:
By epidemiology:
- Endemic goiter - Thyroid enlargement observed in a significant number of
population in a particular locality.
- Sporadic goiter - Goiter occurring sporadically.
By morphology:
- Diffuse goiter - diffusely enlarged thyroid
- Nodular goiter - irregular enlarged thyroid due to nodule formation
- Mixed goiter
By localization:
- Usually located.
- Partially sternal.
- Annular.
- Distilled goiter from embryonic bookmarks (goiter of the tongue root,
additional lobe of the thyroid gland).
Pathophysiology:
- is caused by a violation of the functioning of the immune system under the
influence of provoking factors against the background of a hereditary
predisposition
Classification of thyrotoxicosis:
- Subclinical thyrotoxicosis - a decrease in TSH levels with normal thyroxine
and triiodothyronine values.
- Clinical (manifest) thyrotoxicosis - a decrease in TSH in combination with
elevated levels of thyroxine and triiodothyronine
Diagnosis:
- Ultrasound
- Thyroid scintigraphy
Nodular goiter:
- presence of one or more nodular neoplasms
Examples:
- Uninodular goiter (e.g., cysts, adenoma, cancer)
- Toxic and nontoxic multinodular goiter
Epidemiology:
- at least 2–5% of the general population;
- With age, the prevalence of nodular goiter increases.
- In women, nodular goiter occurs in 5-10 times more often
Pathophysiology:
- There is an active proliferation of a pool of tumor cells that gradually form a
nodule.
- Follicular adenoma is a benign tumor from the follicular epithelium, more often
originating from A-cells.
macrofollicular (simple)
microfollicular (fetal)
trabecular (embryonic)
- Less commonly, adenoma originates from B cells (oncocytoma).
Classification:
Depending on the number of foci, the following are distinguished:
- solitary nodule (single thyroid nodule);
- multinodular goiter (two or more thyroid nodules);
- conglomerate nodular goiter (a conglomerate of soldered nodes).
Depending on the thyroid function, the following are distinguished:
- nodular toxic goiter (hyperthyroidism);
- nodular nontoxic goiter (euthyroidism or hypothyroidism)
Degrees of nodular goiter:
- Grade 1 nodular goiter– the goiter is not visible, but is well palpable;
- Grade 2 nodular goiter – the goiter is palpable and visible on
examination.
Structure of diseases:
- nodular colloidal goiter with varying degrees of proliferation (90%)
- follicular adenoma of the thyroid gland (7–8%);
- thyroid cancer (1–2%)
- other diseases (less than 1%).
Diagnosis:
- palpation
- fine needle aspiration biopsy
- thyroid scintigraphy
- ultrasound